Med Discovery is a Swiss biopharmaceutical company dedicated to the discovery and the development of highly specific treatments for uro-genital cancers.
Our strategy is to develop protein drugs based on the optimization of natural proteins involved in the regulation of biological pathways.
To achieve this we are leveraging a unique in-house expertise in kallikreins, the biggest class of human proteases, combined with an international network in clinical urology.

Our proprietary technology platform to produce protease inhibitors allows Med Discovery to target cancers or other diseases where there is a lack of specific treatment.

Using this approach, Med Discovery intends to become a leading research and development biotech company in the uro-genital field, developing products both in-house and with appropriate partners.
Domain: Therapeutics & Diagnostics, Proteins / Peptides
Contact: Rte. de la Corniche 4
1066 Epalinges / VD
P: 0041 (0) 21 651 90 76

http://www.med-discovery.com
Find an actor

LS2 Annual Meeting 201812.02.2018

The biggest Life Sciences conference in Switzerland takes place at the University of Lausanne February 12-13, 2018

Comment la «Health Valley» séduit les start-ups

«Ici, il y a une vraie convergence entre les technologies informatiques et le domaine médical, créant un...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn